Global Female Sexual Dysfunction Treatment Market Size By Dysfunction, By Treatment Modalities, By Consumer Demographics, By Geographic Scope And Forecast
Published on: 2024-08-08 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Female Sexual Dysfunction Treatment Market Size By Dysfunction, By Treatment Modalities, By Consumer Demographics, By Geographic Scope And Forecast
Female Sexual Dysfunction Treatment Market Size And Forecast
Female Sexual Dysfunction Treatment Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2024 to 2031.
Global Female Sexual Dysfunction Treatment Market Drivers
The market drivers for the Female Sexual Dysfunction Treatment Market can be influenced by various factors. These may include
- Growing Awareness and Acceptance As female sexual dysfunction is becoming more widely recognised as a treatable medical problem, more women are looking for treatment options, which is fueling the market’s expansion.
- Technological Developments New treatment choices, such as medications, gadgets, and therapies, have been made possible by technological advancements in medicine. These options are more efficient and minimally intrusive than conventional approaches.
- Changing Lifestyles Women’s sexual dysfunction can be exacerbated by modern lifestyles marked by stress, inactivity, and bad habits, which raises the need for therapeutic choices.
- Ageing Population As the world’s population ages, women are more likely to experience sexual dysfunction, which is fueling the need for therapy alternatives specifically designed for the elderly.
- Growing Healthcare Expenditure Women are now able to obtain and afford therapies for sexual dysfunction, thanks to rising healthcare spending, especially in developed nations, which is driving market expansion.
- Social and Cultural Factors As attitudes about female sexuality change in society, so do cultural standards. This has increased awareness of sexual dysfunction and encouraged women to seek treatment.
- Regulatory Support New treatment alternatives are developed and approved with the help of supportive regulatory frameworks that put women’s health and well-being first, which grows the market.
- Research and development investment By providing more options, the development of innovative treatments for female sexual dysfunction is fueled by large investments made by pharmaceutical companies, makers of medical devices, and academic institutions.
- Increasing Healthcare Access More women are able to seek treatment for sexual dysfunction as a result of efforts to increase healthcare access, especially in developing nations. This broadens the market’s potential audience.
- Patient Advocacy and Education By increasing knowledge of female sexual dysfunction, patient advocacy groups and educational programmes enable women to pursue treatment choices and stimulate the market.
Global Female Sexual Dysfunction Treatment Market Restraints
Several factors can act as restraints or challenges for the Female Sexual Dysfunction Treatment Market. These may include
- Social Stigma Cultural and societal taboos around talking about sexual health, particularly with regard to women, can prevent them from opening up and getting help.
- Lack of Awareness Due to inadequate education and awareness initiatives, many women may not be aware that FSD is a medical condition or that there are treatment alternatives.
- Restricted Treatment Options Patients and healthcare professionals have fewer FDA-approved options for treating FSD than for treating male sexual dysfunction, which leaves them with less options.
- Efficacy and Safety Issues Patients may be discouraged from seeking or completing therapy if there are issues with the safety or efficacy of a particular treatment.
- Exorbitant Treatment Costs Some patients may find FSD treatment to be financially unaffordable due to expensive treatment options or a lack of insurance coverage.
- Lack of Training for Healthcare Providers It is possible that healthcare professionals are not sufficiently trained to diagnose and treat FSD, which could result in an underdiagnosis and undertreatment of the illness.
- Psychological Factors Women may be discouraged from getting treatment for sexual health problems due to psychological obstacles like guilt, embarrassment, or fear of being judged.
- Underlying Medical problems Treatment and management of FSD may be complicated by the presence of underlying medical problems such as diabetes, cardiovascular disease, or hormone abnormalities.
- Regulatory Obstacles Strict regulations for the licencing of FSD treatments could prevent novel medicines from entering the market or slow down innovation in the area.
- Cultural and Religious Beliefs Beliefs related to culture or religion may have an impact on treatment-seeking behaviours and attitudes towards sexuality, which may affect how easily women with FSD can receive therapy.
Global Female Sexual Dysfunction Treatment Market Segmentation Analysis
The Global Female Sexual Dysfunction Treatment Market is Segmented on the basis of Type of Dysfunction, Treatment Modalities, Consumer Demographics, and, Geography.
Female Sexual Dysfunction Treatment Market, By Type of Dysfunction
- Female Sexual Arousal Disorder Treatment Targets difficulties in becoming sexually aroused despite the presence of desire.
- Female Orgasmic Disorder Treatment Aims to alleviate issues related to achieving orgasm, such as delayed or absent orgasms.
- Dyspareunia Treatment Addresses painful intercourse, often due to medical or psychological factors.
- Vaginismus Treatment Targets involuntary contraction of muscles around the vagina, leading to discomfort or pain during intercourse.
Female Sexual Dysfunction Treatment Market, By Treatment Modalities
- Medication Pharmaceutical interventions including hormonal therapy, antidepressants, or medications targeting specific neurotransmitters.
- Psychotherapy/Counseling Therapeutic interventions focusing on addressing psychological factors contributing to sexual dysfunction.
- Device-based Therapies Innovative devices such as vibrators, vaginal dilators, or pelvic floor exercisers aimed at improving sexual function.
- Surgical Interventions Invasive procedures like labiaplasty or vaginoplasty to address anatomical concerns affecting sexual function.
Female Sexual Dysfunction Treatment Market, By Consumer Demographics
- Age Groups Tailored treatment approaches considering the specific needs and concerns of different age demographics, such as premenopausal, postmenopausal women.
- Underlying Health Conditions Addressing sexual dysfunction in women with comorbidities such as diabetes, hypertension, or depression.
- Lifestyle Factors Understanding the impact of lifestyle choices, stress, relationship dynamics, and cultural influences on female sexual health.
Female Sexual Dysfunction Treatment Market, By Geography
- North America Market conditions and demand in the United States, Canada, and Mexico.
- Europe Analysis of the Female Sexual Dysfunction Treatment Market in European countries.
- Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
- Middle East and Africa Examining market dynamics in the Middle East and African regions.
- Latin America Covering market trends and developments in countries across Latin America.
Key Players
The major players in the Female Sexual Dysfunction Treatment Market are
- AbbVie Inc.
- Allergan plc
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Apricus Biosciences Inc.
- GlaxoSmithKline Plc.
- Pfizer Inc.
- AMAG Pharmaceuticals
- Merck & Co.Inc.
- Cipla Inc
- Duchesnay Inc.
- Sprout Pharmaceuticals Inc.
- Duchesnay Inc.
- Novo Nordisk AS
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
Study Period | 2020-2031 |
Base Year | 2023 |
Forecast Period | 2024-2031 |
HISTORICAL PERIOD | 2020-2022 |
Key Companies Profiled | AbbVie Inc., Allergan plc, F. Hoffmann-La Roche Ltd., Bayer AG, Apricus Biosciences Inc., Pfizer Inc., AMAG Pharmaceuticals, Merck & Co.Inc., Cipla Inc, Sprout Pharmaceuticals Inc. |
Segments Covered | By Dysfunction, By Treatment Modalities, By Consumer Demographics, By and, By Geography. |
Customization scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factorsProvision of market value (USD Billion) data for each segment and sub-segmentIndicates the region and segment that is expected to witness the fastest growth as well as to dominate the marketAnalysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each regionCompetitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiledExtensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market playersThe current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regionsIncludes in-depth analysis of the market of various perspectives through Porter’s five forces analysisProvides insight into the market through Value ChainMarket dynamics scenario, along with growth opportunities of the market in the years to come6-month post-sales analyst support
Customization of the Report
In case of any please connect with our sales team, who will ensure that your requirements are met.